Intrinsic Value of S&P & Nasdaq Contact Us

TCR2 Therapeutics Inc. TCRR NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
44/100
1/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$5.00
+237.8%

TCR2 Therapeutics Inc. (TCRR) has 17 known insider and institutional holders on record. The largest holder is TANG KEVIN C with 4,394,800 shares. Other notable holders include Hofmeister Robert and Jovan-Embiricos Morana.

TCRR Insider Ownership

Top Holder
TANG KEVIN C
4,394,800 shares
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Tang Kevin C 10 Percent Owner 4,394,800 2023-05-30
100%
2 Hofmeister Robert Chief Scientific Officer 100,000 2021-12-10
2%
3 Jovan-embiricos Morana 10 Percent Owner 89,217 2019-12-20
2%
4 Menzel Garry E President and CEO 39,681 2022-12-19
1%
5 Gibson Neil W Director 16,800 2022-12-19
0%
6 Allen Andrew R Director 16,800 2022-12-19
0%
7 Webster Stephen W Director 16,800 2022-12-19
0%
8 Hegde Priti Director 16,800 2022-12-19
0%
9 Hoos Axel Director 16,800 2022-12-19
0%
10 Tomasello Shawn Director 16,800 2022-12-19
0%
11 Olagunju Peter Chief Technical Officer 16,354 2022-12-19
0%
12 Justice Angela Chief People Officer 13,083 2022-12-19
0%
13 Harrison Rosemary Chief Business & Strategy 12,822 2022-12-19
0%
14 Baeuerle Patrick Director 12,100 2020-12-11
0%
15 Cardama Alfonso Quintas Chief Medical Officer 11,775 2022-12-19
0%
16 Sullivan Eric Chief Financial Officer 6,804 2022-12-19
0%
17 Somaiya Mayur Ian Chief Financial Officer 1,473 2020-12-16
0%

No ownership data available for TCRR.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message